Gouty Arthritis Disease Education

Anonymous

Guest
Given the most recent news on Ilaris's non-approval vote for gout with regards to safety, isn't there a clear link that the only reason why Novartis is doing such an initiative right now in the market is to pre-selling Ilaris out of label? Isn't that against our CIA and FDA guidance?
 






Given the most recent news on Ilaris's non-approval vote for gout with regards to safety, isn't there a clear link that the only reason why Novartis is doing such an initiative right now in the market is to pre-selling Ilaris out of label? Isn't that against our CIA and FDA guidance?

Who are they educating? Is it the managers who now have nothing to do? What a waste of money but typical.
 






You mean like when they sent THOUSANDS of reps to the Joslin center @ harvard so we can learn how to dupe doctors about "impaired glucose tolerance & post prandial glucose"
I still get letters from my Merck rep thanking me .